Analysis of vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort study.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 2014772)

Published in BMC Infect Dis on August 01, 2007

Authors

Moacyr S Junior1, Luci Correa, Alexandre R Marra, Luis F A Camargo, Carlos A P Pereira

Author Affiliations

1: Department of Infectious Disease, Universidade Federal de Sao Paulo, Sao Paulo, Brazil. moacyrjunior8@hotmail.com

Articles cited by this

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother (1997) 17.36

SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol (2003) 10.16

Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep (1995) 4.19

Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know. Clin Infect Dis (2000) 3.00

Assessing illness severity: does clinical judgment work? J Chronic Dis (1986) 2.82

Vancomycin use in a university medical center: comparison with hospital infection control practices advisory committee guidelines. Infect Control Hosp Epidemiol (1996) 2.27

The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study. JAMA (1993) 2.18

Risk factors for mortality in Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol (1998) 1.57

Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality. Infect Control Hosp Epidemiol (1999) 1.25

Control of nosocomial antimicrobial-resistant bacteria: a strategic priority for hospitals worldwide. Clin Infect Dis (1997) 1.00

Appropriateness of vancomycin use in the emergency department. Ann Emerg Med (1998) 0.94

Excessive use of vancomycin: a successful intervention strategy at an academic medical center. Infect Control Hosp Epidemiol (2000) 0.94

Prevention and control of vancomycin resistance in gram-positive coccal microorganisms: fire prevention and fire fighting. Infect Control Hosp Epidemiol (1996) 0.85

Evaluation of vancomycin use in a pediatric teaching hospital based on CDC criteria. Infect Control Hosp Epidemiol (1997) 0.83

Vancomycin prescribing practices in hospitalized chronic hemodialysis patients. Am J Kidney Dis (2000) 0.81

Vancomycin in Oregon: who's using it and why. Infect Control Hosp Epidemiol (1999) 0.81

Articles by these authors

Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance study. J Clin Microbiol (2011) 1.54

Decreasing mortality in severe sepsis and septic shock patients by implementing a sepsis bundle in a hospital setting. PLoS One (2011) 1.35

Nosocomial bacteremia: clinical significance of a single blood culture positive for coagulase-negative staphylococci. Infect Control Hosp Epidemiol (2005) 1.29

Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting. Diagn Microbiol Infect Dis (2013) 1.17

Physicians' perceptions, beliefs, attitudes, and knowledge concerning antimicrobial resistance in a Brazilian teaching hospital. Infect Control Hosp Epidemiol (2007) 1.16

Impact of a program to prevent central line-associated bloodstream infection in the zero tolerance era. Am J Infect Control (2010) 1.06

A controlled trial of universal gloving versus contact precautions for preventing the transmission of multidrug-resistant organisms. Am J Infect Control (2007) 1.02

A program for sustained improvement in preventing ventilator associated pneumonia in an intensive care setting. BMC Infect Dis (2012) 1.02

Bloodstream infection after kidney transplantation: epidemiology, microbiology, associated risk factors, and outcome. Transplantation (2010) 1.01

Nosocomial bloodstream infections in Brazilian pediatric patients: microbiology, epidemiology, and clinical features. PLoS One (2013) 0.88

Controlled trial measuring the effect of a feedback intervention on hand hygiene compliance in a step-down unit. Infect Control Hosp Epidemiol (2008) 0.86

Beta-lactam resistance mechanisms in Pseudomonas aeruginosa strains causing bloodstream infections: comparative results between Brazilian and American isolates. Microb Drug Resist (2012) 0.83

Secular trends of candidemia in a tertiary care hospital. Am J Infect Control (2010) 0.82

The effect of limiting antimicrobial therapy duration on antimicrobial resistance in the critical care setting. Am J Infect Control (2008) 0.82

Control of multi-resistant bacteria and ventilator-associated pneumonia: is it possible with changes in antibiotics? Braz J Infect Dis (2007) 0.79

High success and low mortality rates with non-invasive ventilation in influenza A H1N1 patients in a tertiary hospital. BMC Res Notes (2011) 0.78

Secular trends in the epidemiology of Clostridium difficile infection (CDI): relationship with alcohol gel and antimicrobial usage in a hospital. Int J Infect Dis (2013) 0.77

Measuring hand hygiene compliance in a hematology-oncology unit: a comparative study of methodologies. Am J Infect Control (2013) 0.76

Nephrotoxicity and efficacy assessment of polymyxin use in 92 transplant patients. Antimicrob Agents Chemother (2013) 0.75

Catheter related bloodstream infection (CR-BSI) in ICU patients: making the decision to remove or not to remove the central venous catheter. PLoS One (2012) 0.75

Monitoring for HHV-6 infection after renal transplantation: evaluation of risk factors for sustained viral replication. Transplantation (2013) 0.75

Bacterial reduction of alcohol-based liquid and gel products on hands soiled with blood. Am J Infect Control (2011) 0.75

The effect of contact precautions on hand hygiene compliance. Am J Infect Control (2012) 0.75

Successful prevention of tracheostomy associated pneumonia in step-down units. Am J Infect Control (2011) 0.75

Contact precautions in the intensive care unit setting: 12 years of surveillance. Am J Infect Control (2012) 0.75

Implementation of an antibiotic prophylaxis protocol in an intensive care unit. Am J Infect Control (2012) 0.75